Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Biotech
HHS delivers stop work order to Atlanta biotech, pulls funding
In June 2024, the government granted GeoVax $24.3 million to run a 10,000-participant phase 2b study for its next-gen COVID vaccine.
Gabrielle Masson
Apr 16, 2025 11:02am
'Highly unlikely' BARDA will pull bird flu vax funding: Arcturus
Mar 7, 2025 10:24am
HHS reevaluates $590M bird flu deal with Moderna: report
Feb 27, 2025 11:07am
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
Jan 21, 2025 8:24am
COVID antibodies shut down variants, earn $35M BARDA bucks
Oct 9, 2024 2:00pm
GigaGen garners up to $135M BARDA bucks to beat botulism
Oct 3, 2024 8:00am